How the Pivotal Trial for LivaNova’s OSA Neurostimulator Is Different from the Rest
When testing the aura6000 implant, LivaNova didn’t exclude patients who have historically been seen as poor candidates.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
